Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 687-692

  Jackson, Jeffrey R ^a   Bolognese, Brian ^a   Hillegass, Leonard ^a   Kassis, Shouki ^a   Adams, Jerry ^a   Griswold, Don E ^a   Winkler, James D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; ANGIOGENESIS INHIBITOR; COLLAGEN TYPE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GRANULOMA; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031934170     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Appleton I, Brown NJ, Willis D, Colville-Nash PR, Alam C, Brown JR and Willoughby DA (1996) The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis. J Pathol 180:90-94.
2. Badger AM, Bradbeer JN, Votta B, Lee JC, Adams JL and Griswold DE (1996) Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J Pharmacol Exp Ther 279:1453-1461.
3. BenEzra D, Hemo I and Maftzir G (1990) In vivo angiogeneic activity of interleukins. Arch Ophthamol 108:573-576.
4. BenEzra D and Maftzir G (1996) Antibodies to IL-1 and TNF-alpha but not to bFGF or VEGF inhibit angiogenesis. Invest Ophthalmol Visual Sci 37:4664.
5. Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P and Fiers W (1996) The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J 15:1914-1923.
6. Colville-Nash PR, Alam CAS, Appleton I, Browne JR, Seed MP and Willoughby DA (1995) The pharmacological modulation of angiogenesis in chronic granulomatous inflammation. J Pharmacol Exp Ther 274:1463-1472.
7. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR and Lee JC (1995) SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364:229-233.
8. Dinarello CA (1991) Inflammatory cytokines: Interleukin-1 and tumor necrosis factor as effector molecules in autoimmune diseases. Curr Opin Immunol 3:941-948.
9. Fajardo LF, Kwan HH, Kowalski J, Prionas SD and Allison AC (1992) Dual role of tumor necrosis factor-α in angiogenesis. Am J Pathol 140:539-544.
10. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Med 1:27-31.
11. Griswold DE, Hillegass LM, Meunier PC, Dimartino MJ and Hanna N (1988) Effect of inhibitors of eicosanoid metabolism in murine collagen-induced arthritis. Arthrit Rheum 31:1406-1412.
12. Gross J, Azizkhan RG, Biswas C, Bruns RR, Hsieh DST and Folkman J (1981) Inhibition of tumor growth, vascularization, and collagenolysis in the rabbit cornea by medroxyprogesterone. Proc Natl Acad Sci USA 78:1176-1180.
13. Jackson JR (1996) Angiogenesis and inflammation. Pharmacol Rev Commun 8:81-86.
14. Jackson JR, Seed MP, Kircher CH, Willoughby DA and Winkler JD (1997) The co-dependence of angiogenesis and chronic inflammation. FASEB J 11:457-465.
15. Juszczak RJ, Turchin H, Truneh A, Culp J and Kassis S (1991) Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine p56-lck with CD4 in human T lymphocytes. J Biol Chem 266:11176-11183.
16. Lee JC, Badger AM, Griswold DE, Dunnington D, Truneh A, Votta B, White JR, Young PR and Bender PE (1993) Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci 696:149-170.
17. Lee JC, Griswold DE, Votta B and Hanna N (1988) Inhibition of monocyte IL-1 production by the anti-inflammatory compound, SK&F 86002. Int J Immunopharmacol 10:835-843.
18. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL and Young PR (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
19. Lee JC, Rebar L and Laydon JT (1989) Effect of SK&F 86002 on cytokine production by human monocytes. Agents Actions 27:277-279.
20. Olivera DL, Esser KM, Lee JC, Greig RG and Badger AM (1992) Beneficial effects of SK&F 105809, a novel cytokine-suppressive agent, in murine models of endotoxin shock. Circ Shock 37:301-306.
21. Peacock DJ, Banquerigo ML and Brahn E (1992) Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175:1135-1138.
22. Piguet PF, Grau GE, Vesin C, Loetsher H, Gentz R and Lesslauer W (1992) Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510-514.
23. Pouliot M, Baillargeon J, Lee JC, Cleland LG and James MJ (1997) Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J Immunol 158:4930-4937.
24. Young PR, McLaughlin MM, Kumar S, Kassis S, Doyle ML, McNulty D, Gallagher TF, Fisher S, McDonnell PC, Carr SA, Huddleston MJ, Seibel G, Porter TG, Livi GP, Adams JL and Lee JC (1997) Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site. J Biol Chem 272:12116-12121.